Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Only for single-use vials
Elevated microRNA-34a in metabolic research models reduces NAD+ levels and SIRT1 [PMID: 23834033] Laboratory literature summary: Elevated microRNA-34a in metabolic research models reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT
[59] [60] Injection side effects include skin rash, itching, chills, fever, hot flushes, nausea and dizziness
While these results are interesting to scientists, they are not proof of safety or effectiveness in humans
US$ 29.14
US$ 20.72
US$ 26.16
